Anhui Wanbang Pharmaceutical Technology Co.,Ltd.

SZSE:301520 Stock Report

Market Cap: CN¥2.7b

Anhui Wanbang Pharmaceutical TechnologyLtd Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of 301520?
Owner TypeNumber of SharesOwnership Percentage
Private Companies5,339,9508.01%
Institutions6,177,9149.27%
General Public16,194,60324.3%
Individual Insiders38,954,20058.4%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 75.55% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
39.6%
Chunlei Tao
26,427,800CN¥1.1b0%no data
14.6%
Xinluo Xu
9,726,200CN¥393.8m0%no data
6.99%
Hefei Bairuibang Equity Investment Partnership Enterprise (Limited Partnership)
4,661,000CN¥188.7m0%no data
2.34%
Jiangsu Tianhui Sumintou Health Industry Investment Management Co.
1,562,500CN¥63.3m0%no data
2.1%
Yeyin Qian
1,401,900CN¥56.8m-24.8%no data
2.1%
Ying Shen
1,398,300CN¥56.6m0%no data
1.5%
Rongtong Fund Management Co. Ltd.
1,000,000CN¥40.5m0%0.13%
1.33%
Shihezi Longtai Equity Investment Management Partnership Enterprise (Limited Partnership)
886,983CN¥35.9m-42.9%100.0%
1.17%
Hangzhou Taige Equity Investment Partnership Enterprise (LP)
776,850CN¥31.5m0%no data
1.02%
Hefei Hangbang Enterprise Management Partnership Enterprise (Limited Partnership)
678,950CN¥27.5m0%no data
0.44%
Guangdong Province Occupational Pension Scheme
290,736CN¥11.8m0%0.83%
0.38%
Essence Fund Management Co., Ltd
255,040CN¥10.3m0%0.04%
0.28%
Everbright Asset Management Co., Ltd.
187,801CN¥7.6m0%0.09%
0.28%
UBS Asset Management AG
184,938CN¥7.5m0%no data
0.25%
Huatai Securities (Shanghai) Asset Management Co., Ltd.
165,896CN¥6.7m0%0.05%
0.24%
CITIC Securities Company Limited, Asset Management Arm
157,631CN¥6.4m0%0.01%
0.18%
Ping An of China Asset Management (Hong Kong) Company Limited
120,787CN¥4.9m0%no data
0.18%
Goldman Sachs Group, Investment Banking and Securities Investments
118,183CN¥4.8m0%no data
0.17%
China Merchants Securities Asset Management Co., Ltd.
113,597CN¥4.6m0%0.07%
0.16%
CIB Fund Management Co., Ltd
105,689CN¥4.3m0%0.04%
0.1%
Jinxin Fund Management Co., Ltd.
68,000CN¥2.8m0%0.07%
0.031%
China Southern Asset Management Co., Ltd.
20,551CN¥832.2k0%no data
0.03%
Golden Trust SinoPac Fund Management Co., Ltd.
20,000CN¥809.8k0%0.01%
0.029%
HuaAn Fund Management Company Ltd.
19,060CN¥771.7k0%no data
0.025%
Penghua Fund Management Co., Ltd.
16,845CN¥682.1k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/27 15:19
End of Day Share Price 2024/12/27 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Anhui Wanbang Pharmaceutical Technology Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution